ArticleSignal transduction and targeted therapy2025

IL-27: overclocking cytotoxic T lymphocytes to boost cancer immunotherapy.

Silvia Dusi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.